- Benchmark ASINB0F6VGLDZM
- MarketplaceUK
- Category ID22746136031
- Analyzed Products
- Keywordhair growth serum, rosemary hair serum, hair loss serum
- Price Range-
- Minimum Net Profit Margin10.00%
- MOQ100
- Est. Purchasing CostNo price data
- Data Date2026-07-23
- Your Budget (for new listing) (CNY)¥500,000.00
Report summary from Keble AI Agent: Listing
结论很直接：这个市场不该进入。 现在已经是明显的价格战高风险区，新品牌新品成功率只有2.44%~8.33%，而且31个新品牌里只有Pilgrim真正跑出一条可复制的成功线，说明市场不是“能不能做”，而是“多数人做进去也赚不到钱”。
证据先看竞争和利润：48个新释放里，只有4个能盈利，91.49%不盈利；按新品牌口径看，41个新品牌新品里只有1个成功，成功率2.44%，这已经远低于10%的高风险线。 收益结构也很差，市场新产品利润区间只有-13.15%到10.01%，说明大部分新品都被运费、平台费和售价压得很薄；典型失败样本是 YijiaXingzhou 的 B0GGRFH1KN，售价£4.37，利润率-42.93%，以及 B0GGRCRN8X，售价£7.86，利润率-12.72%，这类低价切入基本就是被成本直接打穿。虽然有 Be Bodywise 和 Bare Anatomy 这样的老品牌能做出 16.77%、17.86% 的利润率，但它们靠的是品牌力、资源和高评论基础，不是普通新商家能直接复制的路径；同时，Be Bodywise 的 B0GL8Y61X5、B0GGJ216BY 都有1611条评论，B0F6VGLDZM 也有282条评论，已经接近或落在“强投放/高压竞争”区间，说明这个赛道里存在明显的强势对手。你自己的预算50万人民币，够单个ASIN前几个月的供货、运费和推广，但不够抹平研发、品牌和认证成本；而且当前真正能赚钱的新品，往往依赖配方升级、外观差异和强品牌心智，不是基础款能赢。
对两类玩家都不友好。 大品牌如果硬进，至少要准备更重的研发和品牌投入，并直接对标 Be Bodywise 的 B0GL8Y61X5、B0GGJ216BY，Bare Anatomy 的 B0FTSBJGMK、B0CT5FKBR7；但这不代表值得做，只代表“有钱也要拼得很重”。小商家这边，唯一可当参考的真实新品牌成功案例是 Pilgrim 的 B0FY6XLJ5L，售价£15.34，利润率约10%~12%区间、月销约100单、月营收约£460，但这是极少数例外，不是普遍路径。市场已经在加速变难，最近月份的新入场几乎都只在“other”区间，实际可验证盈利样本极少；如果你不是做强差异化、强品牌或高投放打法，不要进。
Recommended Products Features Direction
These products have successfully captured market share and are profitable. Their design and features are suggested for your investment, based on market competition, saturation, and demand.
New Brands
VS
Old Brands
Green indicates better success rate, red indicates poorer success rate. If you are a new brand, focus on the left side; if you are an old brand, focus on the right side.
New Brands
Old Brands
#Budget Requirement
Listing结论很明确：这个市场不值得进入。 你的预算 50万人民币表面上够启动单个ASIN，但市场已经进入明显的价格战和高失败率阶段；现在不是“能不能做”，而是“做进去也很难赚到钱”。
证据很硬：新品牌新上架产品里，盈利率只有 24.4%，不盈利率高达 95.12%；老品牌新上架产品里，盈利率 42.86%，但这主要是 Be Bodywise、Bare Anatomy 这类老牌在吃品牌和资源红利，不是小商家可复制的路径。 其中 Aisisree 作为新品牌，3个产品里 0个明确盈利，两个新上架 ASIN B0GV5GGQX3（£14.94，利润率 8.71%）和 B0GVPLQJVB（未见有效销量）都没有跑通；YijiaXingzhou 更差，3个产品全部亏损，代表性ASIN B0GGRFH1KN 价格 £4.37，利润率 -42.93%，B0GGRCRN8X 也只有 -12.72%。这说明低价切入已经被成本压扁，大多数产品利润率低于10%，属于典型价格战区。真正能赚钱的样本主要来自老品牌：Be Bodywise 的 B0GL8Y61X5 利润率 16.77%，B0GGJ216BY 利润率 17.86%；Bare Anatomy 的 B0FTSBJGMK 也能做到高销量、高利润，但它们最新产品的最新评论量分别高到 876、1611、1611，明显不是小商家自然增长能轻松模仿的；而且市场里还有大量“高评论”竞争者，像 B0F6VGLDZM 282条评论、B0FYPVXJS9 1000条评论、B0FH6KZ1PR 1614条评论，这些更像强投放型对手，不是普通小商家赛道。
对你来说，直接建议是：不要进。 如果你一定要看标杆，Big Brand 只应参考 Be Bodywise 的 B0GL8Y61X5、B0GGJ216BY 和 Bare Anatomy 的 B0FTSBJGMK、B0CT5FKBR7；Small Business 这边，当前没有找到足够可信的“真实小商家成功案例”（<300 reviews/year），反而看到的是新品牌普遍亏损。你的 50万人民币虽然能覆盖前几个月的供货、运费和推广，但不足以支撑研发、品牌和认证的长期投入；而且当前胜出者多数靠品牌力或更重的营销，不是靠普通预算就能复制。
Early sourcing + logistics + marketing budget (GBP)N/AExplains the budgetWith all these investments, who has profitable new releases
How many new listings are released by old brands?14.58%New listing success rate (old brands):42.86%New listing success rate (new brands):2.44%Which new brands have these successful new listings?Which old brands have these successful new listings?Other major expensesR&DAlternatives- 酮康唑去屑洗发水：对脂溢性皮炎、头皮炎症或伴随脱发的人更容易购买和坚持使用，成本通常低于精华类产品。
- 米诺地尔外用溶液/泡沫：在脱发管理里属于更成熟、常见的替代方案，虽然不是“天然”路线，但购买门槛和获取便利性较高。
- 咖啡因防脱洗发水：比精华更容易纳入日常洗护流程，适合想先试低门槛方案、且不想额外增加护发步骤的用户。
- 头皮去角质/清洁型磨砂或酸类头皮护理：若问题与头皮油脂、堆积、毛囊堵塞相关，这类产品通常比生长精华更便宜，也更容易形成使用习惯。
- 生发营养补充剂中的基础款（如生物素、铁、锌配方）：对怀疑与营养不足相关的用户，是比长期涂抹精华更省事的替代路径。
- 头皮按摩刷/按摩器配合基础洗发水：几乎没有学习成本，作为低预算、低承诺的日常替代方式，能满足一部分想‘先做点什么’的用户。
- 发际线遮盖粉/增发纤维：如果用户的核心诉求是即时视觉改善而非长期治疗，这类产品比生长精华更快见效、也更容易接受。
Alternative solutions may pose a risk to your investment in certain markets.
#Brands Investment Analysis
Listing这个市场不值得进入，结论很明确：已经进入价格战高风险区，而且新品牌几乎没有成功空间。 目前可识别的盈利产品只占15.52%，但新上架产品的盈利率只有8.33%，低于10%的高风险线；更关键的是，新品牌新品亏损率高达95.12%，说明大多数新玩家一进来就被打穿。
New products with Highest revenueAisisree
Recent Monthly Revenue (GBP):-(-)B0GVPLQJVBBrand is a new entry in this marketNew ReleaseInsufficient Sales to Meet MOQUnderperformingNot enough sales volume to meet 100 MOQRecent Monthly Revenue (GBP):£2,988.00(200pcs/month)B0GV5GGQX3 (4.6/5 (17 Reviews))Brand is a new entry in this marketNew ReleaseSufficient Sales to Meet MOQWhite HatNet profit margin below 10.00%Old brand with the most profitable new productsBe Bodywise
Recent Monthly Revenue (GBP):£1,999.00(100pcs/month)B0GL8Y61X5 (4.1/5 (1611 Reviews))Brand is an old entry in this marketNew ReleaseSufficient Sales to Meet MOQWhite HatThis listing is deemed profitable
Recent Monthly Revenue (GBP):£1,092.00(50pcs/month)B0GGJ216BY (4.1/5 (1611 Reviews))Brand is an old entry in this marketNew ReleaseSufficient Sales to Meet MOQWhite HatThis listing is deemed profitableRecent Monthly Revenue (GBP):£341.40(20pcs/month)B0F6VGLDZM (4.6/5 (282 Reviews))Brand is an old entry in this marketOld ReleaseSufficient Sales to Meet MOQOld ReleaseThis listing is deemed profitableLeast profitable new productsLeast investment in new productsMost investment in new productsYijiaXingzhou
Recent Monthly Revenue (GBP):-(-)B0GGRFH1KN (3.5/5 (6 Reviews))Brand is a new entry in this marketNew ReleaseInsufficient Sales to Meet MOQUnderperformingNot enough sales volume to meet 100 MOQ
Recent Monthly Revenue (GBP):-(-)B0GGRCRN8X (3.5/5 (6 Reviews))Brand is a new entry in this marketNew ReleaseInsufficient Sales to Meet MOQUnderperformingNot enough sales volume to meet 100 MOQRecent Monthly Revenue (GBP):-(-)B0GPW966RDBrand is a new entry in this marketNew ReleaseInsufficient Sales to Meet MOQUnderperformingNot enough sales volume to meet 100 MOQ#Differentiations
Unique productsCommon productsDifferentiation:- 滚珠走珠设计，和滴管款明显不同
- |
- 多活性配方更丰富，卖点更强
- |
- 价格中等，低门槛更容易吸引下单
B0FTSBJGMK (3.9/5 (876 Reviews))Brand is an old entry in this marketNew ReleaseSufficient Sales to Meet MOQWhite HatThis listing is deemed profitableSales & BSR
Differentiation:- 传统滴管精华外观，与滚珠款区分明显
- |
- 配方叠加Capilia Longa，功能点更完整
- |
- Bare Anatomy品牌更强，图片更容易获得点击
B0CT5FKBR7 (3.9/5 (876 Reviews))Brand is an old entry in this marketOld ReleaseSufficient Sales to Meet MOQOld ReleaseThis listing is deemed profitableSales & BSR
#Net Profit Margins: All vs New
ListingBe Bodywise 才是这里最强的参考对象：它有3个盈利产品、2个新产品盈利，新品盈利率66.67%，单品月收入做到199,900到1,342,240日元级别的体量；其中 B0GL8Y61X5（£19.99，16.77%利润，1611条评论）和 B0GGJ216BY（£21.84，17.86%利润，1611条评论）证明了‘老品牌+高评论+功能堆料+滚珠/差异化形态’能活下来。但这不是小品牌机会，因为它的成功依赖品牌力和高评论基础，不是自然流量型的小店打法。
Profitability difficultyHigh Risk Due to Price CompetitionAll products distribution on different profit levels
All products profit ratio distribution, including all products. For products with insufficient sales or missing profit ratio data, they will be categorized into other rows. This distribution included products that cannot determine the release date.
x < -10.0%-10.0% <= x < 0.0%0.0% <= x < 10.0%10.0% <= x < 20.0%20.0% <= x < 30.0%30.0% <= x < 40.0%x >= 40.0%otherNew products distribution on different profit levels
This are the profit ratios of all new products. There are products without sufficient sales, no more than 100pcs in 3 months, or no profit ratio data, or just released. Those will be considered as 'other'
x < -10.0%-10.0% <= x < 0.0%0.0% <= x < 10.0%10.0% <= x < 20.0%20.0% <= x < 30.0%30.0% <= x < 40.0%x >= 40.0%other#Top Products by Net Profit Margin
Top 20 Profitable Products
Most profitable products ranked by profit value. Only includes products with positive profitability and active sales, regardless of release date.
B0DFH2BCD2Seapuri2025-03-28Yes£19.35300pcs£5805.022.57%£1310.19B0CT5FKBR7Bare Anatomy2024-08-30Yes£13.99500pcs£6995.010.75%£751.97B0GL8Y61X5Be Bodywise2026-02-03Yes£19.99100pcs£1999.016.77%£335.24B0FTSBJGMKBare Anatomy2026-01-16Yes£13.99200pcs£2798.010.83%£303.03B0GGJ216BYBe Bodywise2026-01-13Yes£21.8450pcs£1092.017.86%£195.04
B01518MOZEGEROVITAL2016-05-20Yes£20.9850pcs£1049.015.67%£164.38
B0FY6XLJ5LPilgrim2025-11-24Yes£15.3430pcs£460.212.7%£58.45
B0CK4VC5B5Moerie2023-11-23Yes£26.6110pcs£266.120.95%£55.75B0F6VGLDZMBe Bodywise2025-07-17Yes£17.0720pcs£341.414.36%£49.03Top 20 Profitable New Products
Most profitable new products ranked by profit value. Only includes newly released products with positive profitability and active sales.
B0GL8Y61X5Be Bodywise2026-02-03Yes£19.99100pcs£1999.016.77%£335.24B0FTSBJGMKBare Anatomy2026-01-16Yes£13.99200pcs£2798.010.83%£303.03B0GGJ216BYBe Bodywise2026-01-13Yes£21.8450pcs£1092.017.86%£195.04B0FY6XLJ5LPilgrim2025-11-24Yes£15.3430pcs£460.212.7%£58.45#New Product Success Rates
Listing这个市场不适合进入：新品牌新品成功率只有2.50%（1/40），整体新品成功率也只有8.51%（4/47），已经低于你要求的10%高风险线；同时失败新品占91.49%，而且大量产品利润率只在11.79%~12.7%附近，明显是价格战高压区，不是健康市场。更关键的是，市场里成功几乎被老品牌和少数强势品牌拿走，新品牌真正的可复制成功案例极少，说明新进入者门槛很高。
New products success rate.
What is the ratio of profitable products
Profitable (Unidentifiable released date)Profitable (Old product)Profitable (New product)Profitable (New product on old listing)New products but non profitableProfitable new products divide by brands
What is the ratio of different brands owning all profitable new products
Be BodywiseBare AnatomyPilgrimNonprofitable new products divide by brands
What is the ratio of different brands owning all nonprofitable new products
Other#Success Rate by Entry Time
Listing这个市场不值得进入，已经接近或进入过度拥挤和价格战区。 近一年新品牌成功率只有2.5%，新上架产品整体盈利率只有8.33%，而新品牌新上架失败率高达97.5%；同时，最近月份新入场几乎都在亏，说明竞争正在加速变难，不是变容易。
How many products released each year
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
How many products released each month
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
#Net Profit Margins by Entry Time
Different profit ratios of products released in year
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
Time/Profit% x < -10.0% -10.0% <= x < 0.0% 0.0% <= x < 10.0% 10.0% <= x < 20.0% 20.0% <= x < 30.0% 30.0% <= x < 40.0% x >= 40.0% other 2022 0 0 0 0 0 0 0 0 2023 0 0 0 0 0 0 0 0 2024 0 0 0 0 0 0 0 0 2025 0 1 1 1 0 0 0 16 2026 0 1 1 3 0 0 0 24 ≥ 10% Profitable< 10% UnprofitableUnidentifiableDifferent profit ratios of products released in month
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
Time/Profit% x < -10.0% -10.0% <= x < 0.0% 0.0% <= x < 10.0% 10.0% <= x < 20.0% 20.0% <= x < 30.0% 30.0% <= x < 40.0% x >= 40.0% other 2025/7 0 0 0 0 0 0 0 1 2025/8 0 0 0 0 0 0 0 1 2025/9 0 1 1 0 0 0 0 4 2025/10 0 0 0 0 0 0 0 7 2025/11 0 0 0 1 0 0 0 2 2025/12 0 0 0 0 0 0 0 1 2026/1 0 1 0 2 0 0 0 6 2026/2 0 0 0 1 0 0 0 3 2026/3 0 0 1 0 0 0 0 0 2026/4 0 0 0 0 0 0 0 6 2026/5 0 0 0 0 0 0 0 4 2026/6 0 0 0 0 0 0 0 4 ≥ 10% Profitable< 10% UnprofitableUnidentifiable#Case Study
Success CasesBare AnatomyB0CT5FKBR7 (3.9/5 (876 Reviews))Bare Anatomy Advanced Hair Growth Serum | Redensyl, Anagain, Baicapil & Rosemary | Reduces Hair Fall | Thicker & Fuller Looking Hair | For Men & Women | 30ml
This listing is deemed profitablePrice (GBP)£13.99Released TypeOld Release (2024-08-30)Brand is an old entry in this marketSize and Weight10.8 x 4.9 x 4.7 cm, 30.00gProfitable Factors
Established brand with longevityBased on old ASINDistinct functions and featuresDesign & Appearance
30ml滴管精华瓶，偏传统精华形态，和同类滚珠型竞品形成明显区分Key Buying Motive
在常见的Redensyl+Anagain+Baicapil基础上，额外加入1% Capilia Longa，并结合迷迭香、Biotin、Rice Water，功能堆料更完整Target Customers
适合更关注配方完整度、偏好传统滴管涂抹而非滚珠使用方式、且同时想兼顾男女通用的防脱/增发人群Early Investment
Investment
Monthly Revenue (Recent) (GBP)£6,995.00500 sold in the past 30 days · as of 2026年7月Net Profit Margin
Sea Freight10.67% / 10.75%Peak / Non PeakRail Freight9.47% / 9.55%Peak / Non PeakAir Freight9.47% / 9.55%Peak / Non PeakSales & BSR Performance
Bare AnatomyB0FTSBJGMK (3.9/5 (876 Reviews))Bare Anatomy Advanced Hair Growth Serum Roll-On| 3% Redensyl + 4% Anagain + 2% Baicapil + 5% Rosemary, Rice Water, Biotin & Saw Palmetto| Reduces Hair Fall, Supports Hair Growth for Men & Women | 25ml
This listing is deemed profitablePrice (GBP)£13.99Released TypeNew Release (2026-01-16)Brand is an old entry in this marketSize and Weight13.4 x 5.5 x 2.9 cm, 25.00gProfitable Factors
Based on old ASINDistinct functions and featuresLow pricing strategyDesign & Appearance
滚珠式走珠瓶设计，便于头皮定点涂抹，和常见滴管/喷雾型竞品区分明显Key Buying Motive
在常见的Redensyl + Anagain基础上，叠加Baicapil、5%迷迭香、米水、生物素和锯棕榈，功能堆料更完整, 滚珠式无脏手涂抹，适合局部稀疏区域精准护理Target Customers
面向希望用更低客单价尝试多活性头皮护理方案、且偏好滚珠便捷使用体验的脱发/发量稀疏人群Early Investment
Investment
Monthly Revenue (Recent) (GBP)£2,798.00200 sold in the past 30 days · as of 2026年7月Net Profit Margin
Sea Freight10.76% / 10.83%Peak / Non PeakRail Freight9.73% / 9.80%Peak / Non PeakAir Freight9.73% / 9.80%Peak / Non PeakSales & BSR Performance
Loading samples... 40%